<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="adcy5-dysk" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">adcy5-dysk</book-part-id>
      <title-group>
        <title><italic toggle="yes">ADCY5</italic>-Related Dyskinesia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shaw</surname>
            <given-names>Chris</given-names>
          </name>
          <degrees>BS</degrees>
          <aff>School of Medicine<break/>University of Washington<break/>Seattle, Washington</aff>
          <email>crs34@uw.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hisama</surname>
            <given-names>Fuki</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Division of Medical Genetics<break/>Department of Medicine <break/>University of Washington<break/>Seattle, Washington</aff>
          <email>fmh2@uw.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Friedman</surname>
            <given-names>Jennifer</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Departments of Neuroscience and Pediatrics<break/>University of California, San Diego<break/>San Diego, California</aff>
          <email>jrfriedman@rchsd.org</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bird</surname>
            <given-names>Thomas D</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Seattle VA Medical Center<break/>Departments of Neurology and Medicine<break/>University of Washington<break/>Seattle, Washington</aff>
          <email>tomnroz@u.washington.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>18</day>
          <month>12</month>
          <year>2014</year>
        </date>
        <date date-type="revised">
          <day>17</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="adamtsl4-eyes" document-type="chapter"><italic toggle="yes">ADAMTSL4-</italic>Related Eye Disorders</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="adnp-dis" document-type="chapter"><italic toggle="yes">ADNP-</italic>Related Intellectual Disability and Autism Spectrum Disorder</related-object>
      <abstract id="adcy5-dysk.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">ADCY5</italic>-related dyskinesia is characterized by infantile- to late-adolescent onset of paroxysmal choreiform, myoclonic, and/or dystonic movements that involve the limbs, neck, and/or face. Dyskinesias are often exacerbated by anxiety (although not by startle, caffeine, or alcohol). Facial &#x02018;twitches&#x0201d; (previously thought to be myokymia) involving the periorbital and/or perioral muscles may also be present. Hypotonia and delayed motor milestones may be present in more severely affected infants. The movement disorder can be static or slowly progressive, with a tendency to stabilize in early middle age. Intellect and life span are normal.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis is established in a proband with a hyperkinetic movement disorder in the absence of structural brain abnormalities and confirmed by the detection of a pathogenic variant in <italic toggle="yes">ADCY5.</italic></p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Anecdotally, medications have had variable effect in suppressing debilitating symptoms. Treatment trials should be determined by the individual&#x02019;s physician, taking into account potential risk/benefit, other medical conditions, allergies, and potential drug-drug interactions. Response to medication is difficult to evaluate because some patients have long periods (weeks) of remission of the dyskinesia.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Physical and occupational therapy may help maintain mobility and function.</p>
          <p><italic toggle="yes">Surveillance:</italic> Most affected individuals are reevaluated annually (or more frequently if medication trials are undertaken) to document disease progression and determine if other interventions are necessary.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Known triggers (anxiety and stress) and possible triggers (intercurrent illness, prolonged inactivity, fatigue, and excitement).</p>
          <p><italic toggle="yes">Pregnancy management:</italic> Potential teratogenic effects of medications given for treatment of dyskinesias should be discussed with affected women of childbearing age, ideally prior to conception.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">ADCY5</italic>-related dyskinesia is inherited in an autosomal dominant manner. <italic toggle="yes">De novo</italic> mutation has been reported. Each child of an affected individual has a 50% chance of inheriting the <italic toggle="yes">ADCY5</italic> pathogenic variant. Prenatal testing for pregnancies at increased risk is possible if the <italic toggle="yes">ADCY5</italic> pathogenic variant has been identified in an affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="adcy5-dysk.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="adcy5-dysk.Tc" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_adcy5-dysk.Tc_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">ADCY5</italic>-Related Dyskinesia: Included Phenotypes&#x000a0;<sup>1</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_adcy5-dysk.Tc_1_1_1_1" valign="top" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Familial dyskinesia with facial myokymia (FDFM)</p></list-item><list-item><p>Familial benign chorea</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="adcy5-dysk.Nomenclature">Nomenclature</xref></p>
            </fn>
            <fn id="adcy5-dysk.TF.c.1">
              <label>1. </label>
              <p>For other genetic causes of these phenotypes, see <xref ref-type="sec" rid="adcy5-dysk.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="adcy5-dysk.Diagnosis">
        <title>Diagnosis</title>
        <p>There are no current published guidelines for the diagnosis of <italic toggle="yes">ADCY5</italic>-related dyskinesia.</p>
        <sec id="adcy5-dysk.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Diagnosis of <italic toggle="yes">ADCY5</italic>-related dyskinesia <bold>should be suspected</bold> in individuals with:</p>
          <list list-type="bullet">
            <list-item>
              <p>Infantile- to late-adolescent onset of paroxysmal choreiform, myoclonic, and/or dystonic movements that involve the limbs, neck, and/or face;</p>
            </list-item>
            <list-item>
              <p>No evidence of structural abnormalities on brain MRI.</p>
            </list-item>
          </list>
        </sec>
        <sec id="adcy5-dysk.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of <italic toggle="yes">ADCY5</italic>-related dyskinesia <bold>is established</bold> in a proband with a hyperkinetic movement disorder in the absence of structural brain abnormalities and confirmed by the detection of a pathogenic variant in <italic toggle="yes">ADCY5</italic> (see <xref ref-type="table" rid="adcy5-dysk.T.summary_of_molecular_geneti">Table 1</xref>).</p>
          <p>Approaches to molecular genetic testing are the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Sequence analysis of <italic toggle="yes">ADCY5</italic>.</bold> No deletions or duplications in <italic toggle="yes">ADCY5</italic> associated with dyskinesia have been reported thus far. To date, only fifteen persons representing simplex (i.e., a single occurrence in a family) cases and members of five families have been proven to have <italic toggle="yes">ADCY5</italic>-related dyskinesia (see <xref ref-type="table" rid="adcy5-dysk.T.confirmed_familial_and_simp">Table 2</xref>).</p>
            </list-item>
            <list-item>
              <p><bold>Use of a multi-gene panel</bold> that includes <italic toggle="yes">ADCY5</italic> and other genes of interest (see <xref ref-type="sec" rid="adcy5-dysk.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
            </list-item>
          </list>
          <table-wrap id="adcy5-dysk.T.summary_of_molecular_geneti" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">ADCY5</italic>-Related Dyskinesia</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_adcy5-dysk.T.summary_of_molecular_geneti_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_adcy5-dysk.T.summary_of_molecular_geneti_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_adcy5-dysk.T.summary_of_molecular_geneti_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_adcy5-dysk.T.summary_of_molecular_geneti_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">ADCY5</italic>
                  </td>
                  <td headers="hd_h_adcy5-dysk.T.summary_of_molecular_geneti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_adcy5-dysk.T.summary_of_molecular_geneti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">7/7&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_adcy5-dysk.T.summary_of_molecular_geneti_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_adcy5-dysk.T.summary_of_molecular_geneti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">None reported</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="adcy5-dysk.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="adcy5-dysk" object-id="adcy5-dysk.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="adcy5-dysk.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="adcy5-dysk.TF.1.2">
                <label>2. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="adcy5-dysk.TF.1.3">
                <label>3. </label>
                <p><xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2011.1252">Chen et al [2011]</xref>, <xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2014.542">Chen et al [2014]</xref>, <xref ref-type="bibr" rid="adcy5-dysk.REF.mencacci.2015.80">Mencacci et al [2015]</xref>, YZ Chen [personal observation]</p>
              </fn>
              <fn id="adcy5-dysk.TF.1.4">
                <label>4. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="adcy5-dysk.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="adcy5-dysk.Clinical_Description">
          <title>Clinical Description</title>
          <p>Thus far, only fifteen individuals representing simplex (i.e., a single occurrence in a family) cases and members of seven families with <italic toggle="yes">ADCY5</italic>-related dyskinesia have been reported [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2011.1252">Chen et al 2011</xref>; <xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2014.542">Chen et al 2014</xref>; YZ Chen, personal observation]. Therefore, the phenotypic spectrum of this disorder is still being elucidated. Affected individuals identified to date have overlapping but not identical clinical manifestations with wide-ranging clinical severity.</p>
          <p><bold>Neurologic manifestations.</bold> All affected individuals reported to date have had episodes of choreiform, myoclonic, and/ or dystonic movements which primarily affect the limbs, face, and/or neck. Typically the abnormal movements first appear during infancy, childhood, or early adolescence (range: neonatal period to age 19 years) [<xref ref-type="bibr" rid="adcy5-dysk.REF.fernandez.2001.486">Fernandez et al 2001</xref>].</p>
          <p>In those with milder manifestations, the abnormal movements involve the face and distal limbs and (although minimally affecting function) are socially debilitating. Some affected individuals may be described as &#x0201c;excessively clumsy.&#x0201d;</p>
          <p>In those with more severe manifestations, the hypotonia or movement disorder can interfere with activities of daily living. For example, proximal adventitious movements and/or weakness and hypotonia may affect the ability to ambulate, requiring the use of wheelchairs.</p>
          <p>The abnormal movements are continual during waking hours, and have been noted to persist during sleep, particularly in infancy. Several affected individuals have noted severe, sleep-disrupting movements [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2014.542">Chen et al 2014</xref>; YZ Chen, personal observation; <xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</xref>], which occurred during stages N2 and N3 of sleep and were not associated with epileptiform discharges in one individual [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2014.542">Chen et al 2014</xref>].</p>
          <p>A curious feature observed in some individuals is the occurrence of long periods (days to weeks) of remission.</p>
          <p>The movements are often exacerbated by anxiety (although not by startle, caffeine, or alcohol). Some report that episodes are more frequent in the morning or when tired. One woman reported that her choreiform movements were precipitated by enforced inactivity (e.g., as during a road trip), and could often be alleviated by voluntary movement.</p>
          <p>Facial &#x02018;twitches&#x0201d; (previously thought to be myokymia) involving the periorbital and/or perioral muscles may also be present. Twitches were also documented in limb muscles in one individual [<xref ref-type="bibr" rid="adcy5-dysk.REF.fernandez.2001.486">Fernandez et al 2001</xref>].</p>
          <p>Hypotonia and delayed motor milestones may be present in more severely affected infants.</p>
          <p>Dysarthria and hypotonia have been reported in some affected individuals [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2014.542">Chen et al 2014</xref>, <xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</xref>, <xref ref-type="bibr" rid="adcy5-dysk.REF.mencacci.2015.80">Mencacci et al 2015</xref>].</p>
          <p>Neurologic examination can vary widely between individuals and in the same individual over time. Examination may reveal:</p>
          <list list-type="bullet">
            <list-item>
              <p>A mixed movement disorder that may include prominent choreiform movements usually affecting the hands and/or feet, often characterized as piano playing movements;</p>
            </list-item>
            <list-item>
              <p>Myoclonic and dystonic movements;</p>
            </list-item>
            <list-item>
              <p>Non-myokymic facial twitching, hyperreflexia of the lower limbs, and intermittent head or limb tremors [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2014.542">Chen et al 2014</xref>];</p>
            </list-item>
            <list-item>
              <p>Axial hypotonia with limb and axial weakness including severe neck weakness [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2014.542">Chen et al 2014</xref>; <xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</xref>; YZ Chen, personal observation].</p>
            </list-item>
          </list>
          <p>The natural history varies. In most, the abnormal movements are static or slowly progressive with increased severity and frequency. In some cases, choreiform movements have been more constant, and less paroxysmal, from onset [<xref ref-type="bibr" rid="adcy5-dysk.REF.mencacci.2015.80">Mencacci et al 2015</xref>]. The overall tendency is for the abnormal movements to stabilize in early middle age, at which point they may improve in some.</p>
          <p>Intellect and life span are normal in individuals with <italic toggle="yes">ADCY5-</italic>related dyskinesia.</p>
          <p><bold>Cardiac complications.</bold>
<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2011.1252">Chen et al [2011]</xref> reported that five individuals in a family with <italic toggle="yes">ADCY5-</italic>related dyskinesia also had congestive heart failure. Because <italic toggle="yes">ADCY5</italic> encodes a specific adenylyl cyclase that is highly expressed in both striatum and myocardium [<xref ref-type="bibr" rid="adcy5-dysk.REF.matsuoka.1997.498">Matsuoka et al 1997</xref>], these observations suggest that mutation of <italic toggle="yes">ADCY5</italic> could contribute to cardiac pathology; further study is required.</p>
          <p>
            <bold>Studies</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Needle electromyogram (EMG)</bold> in two individuals with facial muscle twitching initially revealed what was thought to be myokymia (see Note) [<xref ref-type="bibr" rid="adcy5-dysk.REF.fernandez.2001.486">Fernandez et al 2001</xref>]; however, subsequent EMG studies in the same individuals suggested centrally driven irregular muscle movements which were also observed in other muscles, including the orbicularis oculi, tongue, frontalis, and dorsal interosseus muscles. No fibrillations, fasciculations, myokymia, or myotonia were noted on EMG.</p>
              <p>Note: Myokymia is clinically characterized by a localized, fine, rippling motion of muscles under the skin; it can be differentiated from other causes of involuntary muscle movements more precisely by EMG.</p>
            </list-item>
            <list-item>
              <p><bold>Neuroimaging.</bold> Brain MRI in all reported affected individuals has been normal.</p>
              <p>SPECT imaging in one patient showed nonspecific slight hypo-perfusion in the temporal lobes, right-sided basal ganglia, and right cerebellar hemisphere [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2014.542">Chen et al 2014</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="adcy5-dysk.Pathophysiology">
          <title>Pathophysiology</title>
          <p>The mechanism underlying neurologic dysfunction and dyskinesias has not been clearly delineated yet. In <italic toggle="yes">ADCY5</italic>-related dyskinesia, the changes seen in adenylyl cyclase V have been shown to increase intracellular cAMP, which could exert a myriad of effects at the cellular level [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2014.542">Chen et al 2014</xref>].</p>
        </sec>
        <sec id="adcy5-dysk.GenotypePhenotype_Correlation">
          <title>Genotype-Phenotype Correlations</title>
          <p>Currently, the number of patients and families tested is too small to make reliable predictions of phenotypic features based on genotype (<xref ref-type="table" rid="adcy5-dysk.T.confirmed_familial_and_simp">Table 2</xref>).</p>
          <table-wrap id="adcy5-dysk.T.confirmed_familial_and_simp" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Confirmed Familial and Simplex Cases of <italic toggle="yes">ADCY5</italic>-Related Dyskinesia</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_1">Familial or Simplex Case</th>
                  <th id="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2" valign="middle" colspan="3" align="left" scope="colgroup" rowspan="1">Clinical Features</th>
                  <th id="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_3"><italic toggle="yes">ADCY5</italic> Variant</th>
                  <th id="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_4" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_4">Citation</th>
                </tr>
                <tr>
                  <th headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2" id="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Dyskinesia</th>
                  <th headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2" id="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Facial Twitching</th>
                  <th headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2" id="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Hypotonia</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Familial</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="adcy5-dysk.T.adcy5_pathogenic_variants_d">p.Ala726Thr</xref>
                  </td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2011.1252">Chen et al [2011]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Simplex&#x000a0;<sup>1</sup></td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="adcy5-dysk.T.adcy5_pathogenic_variants_d">p.Arg418Trp</xref>
                  </td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2014.542">Chen et al [2014]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Simplex&#x000a0;<sup>1</sup></td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="adcy5-dysk.T.adcy5_pathogenic_variants_d">p.Arg418Trp</xref>
                  </td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2014.542">Chen et al [2014]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Familial</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="adcy5-dysk.T.adcy5_pathogenic_variants_d">p.Ala726Thr</xref>
                  </td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2015.2026">Chen et al [2015]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Familial</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="adcy5-dysk.T.adcy5_pathogenic_variants_d">p.Met1029Lys</xref>
                  </td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2015.2026">Chen et al [2015]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Familial</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="adcy5-dysk.T.adcy5_pathogenic_variants_d">p.Arg418Trp</xref>
                  </td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="adcy5-dysk.REF.mencacci.2015.80">Mencacci et al [2015]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Simplex</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_2 hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="adcy5-dysk.T.adcy5_pathogenic_variants_d">p.Arg418Trp</xref>
                  </td>
                  <td headers="hd_h_adcy5-dysk.T.confirmed_familial_and_simp_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="adcy5-dysk.REF.mencacci.2015.80">Mencacci et al [2015]</xref>
                  </td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="adcy5-dysk.TF.2.1">
                <label>1. </label>
                <p>In the two individuals who represent simplex cases, mutation of <italic toggle="yes">ADCY5</italic> occurred <italic toggle="yes">de novo</italic>.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>Additional cases with confirmed <italic toggle="yes">ADCY5</italic> pathogenic variants are reported in <xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2015.2026">Chen et al [2015]</xref>.</p>
          <p>Of note, the two simplex cases with documented <italic toggle="yes">de novo</italic> pathogenic variants had more severe phenotypes than those with inherited pathogenic variants [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2014.542">Chen et al 2014</xref>].</p>
          <p>One person who improved considerably during adulthood was shown to be mosaic for the variant p.Met1029Lys [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</xref>]. A second individual, thought to be mosaic for p.Arg418Trp, exhibited significantly more mild phenotypic features: with fewer facial twitches, more mild chorea and no dysarthria [<xref ref-type="bibr" rid="adcy5-dysk.REF.mencacci.2015.80">Mencacci et al 2015</xref>]</p>
        </sec>
        <sec id="adcy5-dysk.Penetrance">
          <title>Penetrance</title>
          <p>In the few documented cases of <italic toggle="yes">ADCY5</italic> dyskinesia, penetrance has been 100% in both men and women.</p>
        </sec>
        <sec id="adcy5-dysk.Nomenclature">
          <title>Nomenclature</title>
          <p><italic toggle="yes">ADCY5</italic>-related dyskinesia has been previously described as:</p>
          <list list-type="bullet">
            <list-item>
              <p>A variant of familial essential (&#x02018;benign&#x02019;) chorea [<xref ref-type="bibr" rid="adcy5-dysk.REF.bird.1976.357">Bird et al 1976</xref>, <xref ref-type="bibr" rid="adcy5-dysk.REF.bird.1978.271">Bird &#x00026; Hall 1978</xref>]. Although the term &#x0201c;benign&#x0201d; was used to distinguish the movement disorder from progressive, neurodegenerative forms of chorea such as <related-object link-type="booklink" source-id="gene" document-id="huntington" document-type="chapter">Huntington disease</related-object>, <italic toggle="yes">ADCY5</italic>-related dyskinesia can be disabling and in some instances progressive, and, thus, use of the term &#x0201c;benign hereditary chorea&#x0201d; should be avoided.</p>
            </list-item>
            <list-item>
              <p>&#x0201c;Familial dyskinesia facial myokymia&#x0201d; because the prominent facial twitching was originally thought to be myokymia (see <xref ref-type="sec" rid="adcy5-dysk.Clinical_Description">Clinical Description</xref>); however, more recently EMG studies of affected individuals have revealed that these twitches are not myokymia.</p>
            </list-item>
          </list>
          <p>DYT-<italic toggle="yes">ADCY5</italic> may be an appropriate designation because dystonia is often a prominent feature [<xref ref-type="bibr" rid="adcy5-dysk.REF.marras.2012.1016">Marras et al 2012</xref>].</p>
        </sec>
        <sec id="adcy5-dysk.Prevalence">
          <title>Prevalence</title>
          <p>There are no data available for the prevalence of <italic toggle="yes">ADCY5-</italic>related dyskinesia.</p>
          <p>To date, <italic toggle="yes">ADCY5</italic> pathogenic variants have been found to segregate with the disease in three unrelated families with affected individuals in three or more generations (18 in 1 family, 11 in the 2nd family, and 4 in the 3rd family); four additional smaller families and <italic toggle="yes">ADCY5</italic> pathogenic variants have been identified in two simplex cases (i.e., a single occurrence in a family) [<xref ref-type="bibr" rid="adcy5-dysk.REF.bird.1976.357">Bird et al 1976</xref>, <xref ref-type="bibr" rid="adcy5-dysk.REF.fernandez.2001.486">Fernandez et al 2001</xref>, <xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2014.542">Chen et al 2014</xref>, <xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</xref>].</p>
          <p><italic toggle="yes">ADCY5-</italic>related dyskinesia is probably underrecognized.</p>
        </sec>
      </sec>
      <sec id="adcy5-dysk.Genetically_Related_Allelic_D">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">ADCY5.</italic></p>
      </sec>
      <sec id="adcy5-dysk.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>See <related-object link-type="booklink" source-id="gene" document-id="dystonia-ov" document-type="chapter">Dystonia Overview</related-object>.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="huntington" document-type="chapter">Huntington disease</related-object>, a progressive, neurodegenerative, fatal disorder characterized by motor, cognitive, and psychiatric disturbances, can be differentiated from <italic toggle="yes">ADCY5</italic>-related dyskinesia by: mean age of onset of Huntington disease (35 to 44 years); and presence of choreiform movements that become constant over time.</p>
        <p>Benign hereditary chorea (BHC) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/118700">OMIM</ext-link>) is a relatively rare autosomal dominant condition caused by mutation of <italic toggle="yes">NKX2-1</italic>. BHC presents before age five years; however, in contrast to <italic toggle="yes">ADCY5</italic>-related dyskinesia, symptoms often improve by late adolescence [<xref ref-type="bibr" rid="adcy5-dysk.REF.bird.1978.271">Bird &#x00026; Hall 1978</xref>]. Non-neurologic manifestations have been seen in both disorders; mutation of <italic toggle="yes">NKX2-1</italic> has been associated with pulmonary symptoms and endocrine abnormalities, most commonly hypothyroidism, while <italic toggle="yes">ADCY5</italic> pathogenic variants have rarely coincided with cardiac dysfunction [<xref ref-type="bibr" rid="adcy5-dysk.REF.inzelberg.2011.301">Inzelberg et al 2011</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="pknd" document-type="chapter">Familial paroxysmal kinesigenic dyskinesia</related-object> (PKD) is characterized by unilateral or bilateral involuntary movements precipitated by other sudden movements such as standing up from a sitting position, being startled, or changes in velocity; attacks include combinations of dystonia, choreoathetosis, and ballism; are sometimes preceded by an aura; and do not involve loss of consciousness. Unlike <italic toggle="yes">ADCY5</italic>-related dyskinesia, PKD is more common in men and is precipitated by voluntary movement. PKD is caused by mutation of <italic toggle="yes">PRRT2,</italic> encoding proline-rich transmembrane protein 2 [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2011.1252">Chen et al 2011</xref>, <xref ref-type="bibr" rid="adcy5-dysk.REF.wang.2011.3493">Wang et al 2011</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="pnknd" document-type="chapter">Familial paroxysmal nonkinesigenic dyskinesia</related-object> (PNKD) is characterized by unilateral or bilateral involuntary movements; attacks are spontaneous or precipitated by alcohol, chocolate, coffee or tea, excitement, stress, or fatigue. Attacks involve dystonic posturing with choreic and ballistic movements, may be accompanied by a preceding aura, occur while the individual is awake, and are not associated with seizures. Unlike the episodes in <italic toggle="yes">ADCY5</italic>-related dyskinesia, these episodes may be precipitated by consumption of alcohol or caffeine. In some families, PNKD is caused by mutation of <italic toggle="yes">PNKD,</italic> encoding probable hydrolase PNKD [<xref ref-type="bibr" rid="adcy5-dysk.REF.rainier.2004.1025">Rainier et al 2004</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="glut1" document-type="chapter">Paroxysmal choreoathetosis/spasticity</related-object> (DYT9) presents with dystonic paroxysms affecting the toes, legs, and arms; dysarthria; and changes in perioral sensation, sometimes accompanied by headache. This disorder is caused by mutation of <italic toggle="yes">SLC2A1</italic> leading to a defect in GLUT1 (also known as glucose transporter type 1 deficiency syndrome) [<xref ref-type="bibr" rid="adcy5-dysk.REF.weber.2011.959">Weber et al 2011</xref>].</p>
        <p>Tardive dyskinesia, a hyperkinetic movement disorder associated with long-term use of specific dopamine receptor blocking agents (including neuroleptics and certain antiemetics) [<xref ref-type="bibr" rid="adcy5-dysk.REF.aquino.2014.s113">Aquino &#x00026; Lang 2014</xref>], is often precipitated by a recent dose reduction or a change to a less potent drug.</p>
        <p>Sydenham chorea, a manifestation of acute rheumatic fever, is the most common cause of acquired chorea in childhood, and typically presents between ages five and 12 years. Although carditis and arthritis are other manifestations of rheumatic fever, chorea may be the only clinical sign. Antistreptolysin O (ASO) titers are elevated in a significant proportion of affected individuals.</p>
        <p>Multiple sclerosis can cause continuous facial myokymia in individuals with lesions impinging on the facial nerve as it courses in the dorsolateral pontine tegmentum. Other features &#x02013; particularly abnormalities on brain MRI, which are disseminated in space and time &#x02013; should assist in making the correct diagnosis.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial disorders</related-object> can present with dystonia or other abnormal movements.</p>
        <p>Neurotransmitter disorders include <related-object link-type="booklink" source-id="gene" document-id="drd" document-type="chapter">GTP cyclohydolase deficiency</related-object>, which results in an autosomal dominant dystonia with a dramatic response to treatment with L-dopa.</p>
        <p>The hyperkinetic movements of <italic toggle="yes">ADCY5</italic>-related dyskinesia may be mistakenly thought to be epileptiform; however, normal EEGs, lack of impaired consciousness, and/or lack of response to antiepileptic medication distinguish epilepsy from <italic toggle="yes">ADCY5</italic>-related dyskinesia.</p>
      </sec>
      <sec id="adcy5-dysk.Management">
        <title>Management</title>
        <sec id="adcy5-dysk.Evaluations_Following_Initial">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with <italic toggle="yes">ADCY5</italic>-related dyskinesia, the following are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic consultation with particular attention to documenting the findings on neurologic examination, and response or lack of response to medications</p>
            </list-item>
            <list-item>
              <p>Consideration of cardiac evaluation, as cardiomyopathy may be a manifestation of <italic toggle="yes">ADCY5</italic>-related dyskinesia [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2011.1252">Chen et al 2011</xref>]</p>
            </list-item>
            <list-item>
              <p>Social services consultation (depending on the severity of the paroxysms), as disease severity may qualify some patients for disability or social security benefits</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="adcy5-dysk.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Medication</bold> has been variably effective in suppressing debilitating symptoms. Treatment trials should be determined by the individual&#x02019;s physician, taking into account potential risk/benefit, other medical conditions, allergies, and potential drug-drug interactions. Response to medication is difficult to evaluate in an individual because some patients have long periods (weeks) of remission of the dyskinesia.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Acetazolamide,</bold> which induces a mild alkalosis, has been shown previously to improve the dyskinesia [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</xref>]. In one individual 15 mg/kg/day completely alleviated episodes of dyskinesia for an extended, but non-sustained, period of time [<xref ref-type="bibr" rid="adcy5-dysk.REF.fernandez.2001.486">Fernandez et al 2001</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Propanolol,</bold> which has suppressed dyskinesia in other disorders (including essential tremor, <related-object link-type="booklink" source-id="gene" document-id="pknd" document-type="chapter">paroxysmal kinesigenic dyskinesia</related-object>, and <related-object link-type="booklink" source-id="gene" document-id="ea1" document-type="chapter">episodic ataxia type 1</related-object>), has had variable success in <italic toggle="yes">ADCY5</italic>-related dyskinesia.</p>
            </list-item>
            <list-item>
              <p><bold>Levetiracetam</bold>, an anti-convulsant, helped decrease the severity of adventitious movements in one patient [T Bird, personal observation; J Friedman, personal observation].</p>
            </list-item>
            <list-item>
              <p><bold>Tetrabenazine,</bold> which has been used as a symptomatic treatment for other hyperkinetic disorders, resulted in subjective symptom improvement in two patients [<xref ref-type="bibr" rid="adcy5-dysk.REF.mencacci.2015.80">Mencacci et al 2015</xref>; FM Hisama, personal observation].</p>
            </list-item>
            <list-item>
              <p><bold>Benzodiazepines,</bold> which have been used in symptomatic treatment for other hyperkinetic disorders, have been associated with variable improvement in <italic toggle="yes">ADCY5</italic>-related dyskinesia [J Friedman, personal observation].</p>
            </list-item>
            <list-item>
              <p><bold>Trihexylphenidyl</bold>, an antimuscarinic compound used in treating Parkinson disease, was observed to decrease the intensity and frequency of episodes of dyskinesia in one patient, when paired with tetrabenazine [<xref ref-type="bibr" rid="adcy5-dysk.REF.mencacci.2015.80">Mencacci et al 2015</xref>].</p>
            </list-item>
          </list>
          <p>Of note, little to no improvement was observed after administration of primidone, chlordiazepoxide, amitriptyline, trifluoperazine, trihexylphenidyl, vitamin C, coenzyme Q<sub>10</sub>, carbamazepine, and valproic acid.</p>
          <p><bold>Stress management.</bold> The only exacerbating factor that is observed consistently across affected individuals is the presence of anxiety and exposure to typical life stressors. Further investigation is needed to determine whether stress management techniques or limitation of stressful activities may reduce the number and frequency of movements.</p>
        </sec>
        <sec id="adcy5-dysk.Prevention_of_Secondary_Compl">
          <title>Prevention of Secondary Complications</title>
          <p>Physical and occupational therapy may assist patients in maintaining mobility and function.</p>
        </sec>
        <sec id="adcy5-dysk.Surveillance">
          <title>Surveillance</title>
          <p>There are no published guidelines for surveillance. Most affected individuals are reevaluated in neurology clinics and/ or clinical genetics clinics annually (or more frequently if medication trials are undertaken) to document disease progression and determine if other interventions are necessary.</p>
        </sec>
        <sec id="adcy5-dysk.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>All patients have reported that anxiety and stress worsen disease manifestations.</p>
          <p>Less commonly reported triggers include intercurrent illness, prolonged inactivity, fatigue, and excitement.</p>
        </sec>
        <sec id="adcy5-dysk.Evaluation_of_Relatives_at_Ri">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="adcy5-dysk.Related_Genetic_Counseling_Is">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="adcy5-dysk.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Potential teratogenic effects of medications given for treatment of <italic toggle="yes">ADCY5</italic>-related dyskinesia should be discussed with affected women of childbearing age, ideally prior to conception.</p>
        </sec>
        <sec id="adcy5-dysk.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="adcy5-dysk.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="adcy5-dysk.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">ADCY5</italic>-related dyskinesia is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="adcy5-dysk.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Some individuals diagnosed with <italic toggle="yes">ADCY5</italic>-related dyskinesia have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with <italic toggle="yes">ADCY5</italic>-related dyskinesia may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2014.542">Chen et al 2014</xref>]. The proportion of <italic toggle="yes">ADCY5</italic>-related dyskinesia caused by a <italic toggle="yes">de novo</italic> pathogenic variant is currently unknown, as molecular genetic data are insufficient. When neither parent of a proband with an autosomal dominant condition has the <italic toggle="yes">ADCY5</italic> pathogenic variant or clinical evidence of the disorder, the pathogenic variant is likely <italic toggle="yes">de novo</italic>.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">ADCY5</italic> pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, two possible explanations are germline mosaicism in a parent or a <italic toggle="yes">de novo</italic> pathogenic variant in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include a detailed clinical and family history with molecular genetic testing of both parents if the pathogenic variant has been identified in the proband.</p>
            </list-item>
            <list-item>
              <p>The family history of some individuals diagnosed with <italic toggle="yes">ADCY5</italic>-related dyskinesia may appear to be negative because of failure to recognize the disorder in family members, or mild/late onset of the disease in the affected parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations (e.g., sequence analysis) have been performed on the parents of the proband.</p>
              <p>Note: If the parent is the individual in whom the pathogenic variant first occurred, s/he may have somatic mosaicism for the variant and may be mildly/minimally affected.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents:</p>
          <list list-type="bullet">
            <list-item>
              <p>If a parent of the proband is affected or has the <italic toggle="yes">ADCY5</italic> pathogenic variant, the risk to the sibs of the proband is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">ADCY5</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism in a parent resulting in more than one affected child.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with <italic toggle="yes">ADCY5</italic>-related dyskinesia has a 50% chance of inheriting the pathogenic variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents. If a parent is affected, his or her family members may be at risk.</p>
        </sec>
        <sec id="adcy5-dysk.Related_Genetic_Counseling_Is">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Predictive testing</bold> for at-risk asymptomatic adult family members requires prior identification of the pathogenic variant in the family.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the <italic toggle="yes">ADCY5</italic> pathogenic variant or clinical evidence of the disorder, the pathogenic variant is likely <italic toggle="yes">de novo</italic>. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="adcy5-dysk.Prenatal_Testing_and_Preimpla">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">ADCY5</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for <italic toggle="yes">ADCY5</italic>-related dyskinesia are possible.</p>
        </sec>
      </sec>
      <sec id="adcy5-dysk.Resources">
        <title>Resources</title>
      </sec>
      <sec id="adcy5-dysk.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure</bold>. <italic toggle="yes">ADCY5</italic> consists of 21 exons spanning 173.25 kb. Transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_183357.2">NM_183357.2</ext-link> is 6098 bp in length and encodes the isoform <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_899200.1">NP_899200.1</ext-link>. A shorter alternative transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001199642.1">NM_001199642.1</ext-link> has a different 5&#x02019; untranslated region and is missing a portion of the 5&#x02019; coding region. A functional difference has not been assigned to this structural change or to the shorter isoform that it encodes. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="adcy5-dysk" object-id="adcy5-dysk.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Benign variants.</bold> No benign variants of clinical significance have been documented in the coding region of <italic toggle="yes">ADCY5</italic>.</p>
        <p><bold>Pathogenic variants.</bold> The variant c.2176G&#x0003e;A (p.Ala726Thr) was identified as an inherited change in a large German-American family [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2012.630">Chen et al 2012</xref>] and later detected in another multigenerational family of English-American ancestry [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</xref>]. The variant c.1252C&#x0003e;T (p.Arg418Trp) was identified as a <italic toggle="yes">de novo</italic> change in two separate families [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2014.542">Chen et al 2014</xref>] and more recently shown to be a recurrent <italic toggle="yes">do novo</italic> pathogenic variant in <italic toggle="yes">ADCY5</italic>-related dyskinesia [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</xref>]. A different missense variant, c.1253G&#x0003e;A (Arg418Gln), has also been repeatedly found in <italic toggle="yes">de novo</italic> cases [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</xref>]. The pathogenic variant p.Met1029Lys has been identified in a single three-generation family [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2015.2026">Chen et al 2015</xref>]. A French father and son with chorea and dystonia and a c.2088+1G&#x0003e;A variant affecting a donor splice site was recently reported [<xref ref-type="bibr" rid="adcy5-dysk.REF.carapito.2015.423">Carapito et al 2015</xref>]. No RNA was detected from the mutated allele and ADCY5 RNA concentration was half that in normal controls. The authors postulated <italic toggle="yes">ADCY5</italic> haploinsuffiency as the mechanism, in contrast to the gain-of-function mechanism demonstrated for missense variants [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2014.542">Chen et al 2014</xref>]. This finding is not consistent with heterozygous <italic toggle="yes">Adcy5</italic>-knockout mice, which have normal motor function [<xref ref-type="bibr" rid="adcy5-dysk.REF.iwamoto.2003.16936">Iwamoto et al 2003</xref>]. The effect of pathogenic variants on signaling in the striatum of humans remains unclear.</p>
        <table-wrap id="adcy5-dysk.T.adcy5_pathogenic_variants_d" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p><italic toggle="yes">ADCY5</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1252C&#x0003e;T</td>
                <td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg418Trp</td>
                <td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_3" rowspan="5" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_183357.2">NM_183357.2</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_899200.1">NP_899200.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2176G&#x0003e;A</td>
                <td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala726Thr</td>
              </tr>
              <tr>
                <td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3086T&#x0003e;A</td>
                <td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Met1029Lys</td>
              </tr>
              <tr>
                <td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1253G&#x0003e;A</td>
                <td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg418Gln</td>
              </tr>
              <tr>
                <td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">c.2088+1G&#x0003e;A</td>
                <td headers="hd_h_adcy5-dysk.T.adcy5_pathogenic_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The normal product of <italic toggle="yes">ADCY5</italic> is the adenylyl cyclase type V protein (ADCY5). The longest isoform of ADCY5 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_899200.1">NP_899200.1</ext-link>) consists of 1261 amino acid residues, which are organized into four domains: two 6-helical section transmembrane regions and two cytosolic catalytic regions [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2014.542">Chen et al 2014</xref>].</p>
        <p>The adenylyl cyclase gene family encodes a number of proteins that convert adenosine triphosphate (ATP) to cyclic adenosine-3&#x02019;,5&#x02019;-monophosphate (cAMP), a second messenger molecule that exerts a wide variety of effects via a number of intracellular signaling pathways [<xref ref-type="bibr" rid="adcy5-dysk.REF.buck.1999.79">Buck et al 1999</xref>]. ADCY5 is one of nine different membrane-bound adenylyl cyclases, and converts adenosine triphosphate (ATP) to cyclic adenosine-3&#x02019;,5&#x02019;-monophosphate (cAMP). It is highly expressed in myocardium and striatum [<xref ref-type="bibr" rid="adcy5-dysk.REF.matsuoka.1997.498">Matsuoka et al 1997</xref>]. ADCY5 is especially prevalent in the nucleus accumbens, accounting for 80% of adenylate cyclase activation [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2011.1252">Chen et al 2011</xref>]. Stimulation of ADCY5 by &#x003b2;-adrenergic agonists through a G-protein-coupled receptor induces a conformational change, aligning the two cytoplasmic domains such that they form a catalytic pocket in which ATP can bind [<xref ref-type="bibr" rid="adcy5-dysk.REF.whisnant.1996.6621">Whisnant et al 1996</xref>].</p>
        <p><bold>Abnormal gene product.</bold> The c.2176G&#x0003e;A pathogenic variant occurs in the region of the gene encoding the S6 domain of the transmembrane domain (M1) and the c.1252C&#x0003e;T pathogenic variant occurs in the first catalytic domain (C1b) [<xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2014.542">Chen et al 2014</xref>]. These two pathogenic variants are gain-of-function variants which are hypothesized to increase ADCY5 activity by affecting either the signal transduction pathway following &#x003b2;-adrenergic stimulation or the interaction of the protein with other regulatory molecules. The expression of the c.1252C&#x0003e;T variant has been shown to progressively increase during the first 500 days post conception in striatal tissue [<xref ref-type="bibr" rid="adcy5-dysk.REF.mencacci.2015.80">Mencacci et al 2015</xref>].</p>
      </sec>
      <sec id="adcy5-dysk.References">
        <title>References</title>
        <sec id="adcy5-dysk.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="adcy5-dysk.Literature_Cited.reflist0">
            <ref id="adcy5-dysk.REF.aquino.2014.s113">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aquino</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lang</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <article-title>Tardive dyskinesia syndromes: current concepts.</article-title>
                <source>Parkinsonism Relat Disord.</source>
                <year>2014</year>
                <volume>20</volume>
                <supplement>Suppl 1</supplement>
                <fpage>S113</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">24262160</pub-id>
              </element-citation>
            </ref>
            <ref id="adcy5-dysk.REF.bird.1976.357">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carlson</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <article-title>Familial essential ("benign") chorea.</article-title>
                <source>J Med Genet.</source>
                <year>1976</year>
                <volume>13</volume>
                <fpage>357</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">1003446</pub-id>
              </element-citation>
            </ref>
            <ref id="adcy5-dysk.REF.bird.1978.271">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <article-title>Additional information on familial essential (benign) chorea.</article-title>
                <source>Clin Genet.</source>
                <year>1978</year>
                <volume>14</volume>
                <fpage>271</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">152174</pub-id>
              </element-citation>
            </ref>
            <ref id="adcy5-dysk.REF.buck.1999.79">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Buck</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinclair</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schapal</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cann</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levin</surname>
                    <given-names>LR</given-names>
                  </name>
                </person-group>
                <article-title>Cytosolic adenylyl cyclase defines a unique signaling molecule in mammals.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>1999</year>
                <volume>96</volume>
                <fpage>79</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">9874775</pub-id>
              </element-citation>
            </ref>
            <ref id="adcy5-dysk.REF.carapito.2015.423">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carapito</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paul</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Untrau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Gentil</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ott</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alsaleh</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jochem</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radosavljevic</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Caignec</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>David</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darnier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isidor</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahram</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia.</article-title>
                <source>Movement Dis</source>
                <year>2015</year>
                <volume>30</volume>
                <fpage>423</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">25545163</pub-id>
              </element-citation>
            </ref>
            <ref id="adcy5-dysk.REF.chen.2015.2026">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e9;neret</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korvatska</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonkowski</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stessman</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doummar</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mignot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anheim</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernes</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damon-Perri&#x000e8;re</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Degos</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gras</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hisama</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackenzie</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swanson</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tranchant</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vidailhet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trouillard</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amendola</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorschner</surname>
                    <given-names>MO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eichler</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winesett</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torkamani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roze</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>WH</given-names>
                  </name>
                </person-group>
                <article-title>ADCY5-related dyskinesia: Broader spectrum and genotype-phenotype correlations.</article-title>
                <source>Neurology.</source>
                <year>2015</year>
                <volume>85</volume>
                <fpage>2026</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">26537056</pub-id>
              </element-citation>
            </ref>
            <ref id="adcy5-dysk.REF.chen.2011.1252">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiong</surname>
                    <given-names>ZQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wei</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ni</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>YF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>QJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murong</surname>
                    <given-names>SX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>ZY</given-names>
                  </name>
                </person-group>
                <article-title>Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia.</article-title>
                <source>Nat Genet.</source>
                <year>2011</year>
                <volume>43</volume>
                <fpage>1252</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22101681</pub-id>
              </element-citation>
            </ref>
            <ref id="adcy5-dysk.REF.chen.2014.542">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>YZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bloss</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hisama</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topol</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carson</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pham</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonkowski</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliveira</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott-Van Zeeland</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topol</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Storm</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swanson</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schork</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torkamani</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia.</article-title>
                <source>Ann Neurol.</source>
                <year>2014</year>
                <volume>75</volume>
                <fpage>542</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24700542</pub-id>
              </element-citation>
            </ref>
            <ref id="adcy5-dysk.REF.chen.2012.630">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>YZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsushita</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robertson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rieder</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girirajan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antonacci</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipe</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eichler</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nickerson</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>WH</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant familial dyskinesia and facial myokymia: single exome sequencing identifies a mutation in adenylyl cyclase 5.</article-title>
                <source>Arch Neurol.</source>
                <year>2012</year>
                <volume>69</volume>
                <fpage>630</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22782511</pub-id>
              </element-citation>
            </ref>
            <ref id="adcy5-dysk.REF.fernandez.2001.486">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fernandez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolff</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsushita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graf</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipe</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Familial dyskinesia and facial myokymia (FDFM): a novel movement disorder.</article-title>
                <source>Ann Neurol.</source>
                <year>2001</year>
                <volume>49</volume>
                <fpage>486</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">11310626</pub-id>
              </element-citation>
            </ref>
            <ref id="adcy5-dysk.REF.inzelberg.2011.301">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Inzelberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinberger</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gak</surname>
                    <given-names>E.</given-names>
                  </name>
                </person-group>
                <article-title>Benign hereditary chorea: An update.</article-title>
                <source>Parkinson Relat Disord.</source>
                <year>2011</year>
                <volume>17</volume>
                <fpage>301</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21292530</pub-id>
              </element-citation>
            </ref>
            <ref id="adcy5-dysk.REF.iwamoto.2003.16936">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Iwamoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okumura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwatsugo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawabe</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohtsu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakai</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashimoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Izumitani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sango</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ajiki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toya</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Umemura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goshima</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vatner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishikawa</surname>
                    <given-names>Y.</given-names>
                  </name>
                </person-group>
                <article-title>Motor dysfunction in Type 5 adenylyl cyclase-null mice.</article-title>
                <source>J Biol Chem</source>
                <year>2003</year>
                <volume>278</volume>
                <fpage>16936</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">12665504</pub-id>
              </element-citation>
            </ref>
            <ref id="adcy5-dysk.REF.marras.2012.1016">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marras</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lang</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples.</article-title>
                <source>Neurology.</source>
                <year>2012</year>
                <volume>78</volume>
                <fpage>1016</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">22454269</pub-id>
              </element-citation>
            </ref>
            <ref id="adcy5-dysk.REF.matsuoka.1997.498">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsuoka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Defer</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakanishi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanoune</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Differential expression of type I, II, and V adenylyl cyclase gene in the postnatal developing rat brain.</article-title>
                <source>J Neurochem.</source>
                <year>1997</year>
                <volume>68</volume>
                <fpage>498</fpage>
                <lpage>506</lpage>
                <pub-id pub-id-type="pmid">9003034</pub-id>
              </element-citation>
            </ref>
            <ref id="adcy5-dysk.REF.mencacci.2015.80">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mencacci</surname>
                    <given-names>NE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erro</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiethoff</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hersheson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryten</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balint</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stamelou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quinn</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlden</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>NW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhatia</surname>
                    <given-names>KP</given-names>
                  </name>
                </person-group>
                <article-title>ADCY5 mutations are another cause of benign hereditary chorea.</article-title>
                <source>Neurology.</source>
                <year>2015</year>
                <volume>85</volume>
                <fpage>80</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">26085604</pub-id>
              </element-citation>
            </ref>
            <ref id="adcy5-dysk.REF.rainier.2004.1025">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rainier</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tokarz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ming</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plein</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemons</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albin</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delaney</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alvarado</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fink</surname>
                    <given-names>JK</given-names>
                  </name>
                </person-group>
                <article-title>Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis.</article-title>
                <source>Arch Neurol.</source>
                <year>2004</year>
                <volume>61</volume>
                <fpage>1025</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15262732</pub-id>
              </element-citation>
            </ref>
            <ref id="adcy5-dysk.REF.wang.2011.3493">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>XH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>ZM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liang</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>San-A, Li N, Chen SQ, Guo JF, Jiang H, Shen L, Zheng L, Mao X, Yan WQ, Zhou Y, Shi YT, Ai SX, Dai MZ, Zhang P, Xia K, Chen SD, Tang BS. Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias.</article-title>
                <source>Brain.</source>
                <year>2011</year>
                <volume>134</volume>
                <fpage>3493</fpage>
                <lpage>501</lpage>
                <pub-id pub-id-type="pmid">22120146</pub-id>
              </element-citation>
            </ref>
            <ref id="adcy5-dysk.REF.weber.2011.959">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>YG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamm</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suls</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kempfle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kotschet</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000fc;le</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wuttke</surname>
                    <given-names>TV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maljevic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liebrich</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasser</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludolph</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Paesschen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000f6;ls</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auburger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerche</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect.</article-title>
                <source>Neurology.</source>
                <year>2011</year>
                <volume>77</volume>
                <fpage>959</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">21832227</pub-id>
              </element-citation>
            </ref>
            <ref id="adcy5-dysk.REF.whisnant.1996.6621">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Whisnant</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilman</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dessauer</surname>
                    <given-names>CW</given-names>
                  </name>
                </person-group>
                <article-title>Interaction of the two cytosolic domains of mammalian adenylyl cyclase.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>1996</year>
                <volume>93</volume>
                <fpage>6621</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">8692867</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="adcy5-dysk.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="adcy5-dysk.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>17 December 2015 (fh) Revision: addition of data from <xref ref-type="bibr" rid="adcy5-dysk.REF.chen.2015.2026">Chen et al [2015]</xref> and <xref ref-type="bibr" rid="adcy5-dysk.REF.mencacci.2015.80">Mencacci et al [2015]</xref></p>
            </list-item>
            <list-item>
              <p>18 December 2014 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>29 August 2014 (fh) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
